Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 39
Filtrar
3.
Nature ; 2024 Apr 09.
Artigo em Inglês | MEDLINE | ID: mdl-38594520
8.
Nature ; 2020 Nov 30.
Artigo em Inglês | MEDLINE | ID: mdl-33262498
9.
Nature ; 2020 Nov 23.
Artigo em Inglês | MEDLINE | ID: mdl-33230276
16.
Molecules ; 23(11)2018 Oct 26.
Artigo em Inglês | MEDLINE | ID: mdl-30373170

RESUMO

The immune system is an efficient integrated network of cellular elements and chemicals developed to preserve the integrity of the organism against external insults and its correct functioning and balance are essential to avoid the occurrence of a great variety of disorders. To date, evidence from literature highlights an increase in immunological diseases and a great attention has been focused on the development of molecules able to modulate the immune response. There is an enormous global demand for new effective therapies and researchers are investigating new fields. One promising strategy is the use of herbal medicines as integrative, complementary and preventive therapy. The active components in medical plants have always been an important source of clinical therapeutics and the study of their molecular pharmacology is an enormous challenge since they offer a great chemical diversity with often multi-pharmacological activity. In this review, we mainly analysed the immunomodulatory/antinflammatory activity of Echinacea spp. and Curcuma longa, focusing on some issues of the phytochemical research and on new possible strategies to obtain novel agents to supplement the present therapies.


Assuntos
Curcumina/farmacologia , Echinacea/química , Fatores Imunológicos/farmacologia , Extratos Vegetais/farmacologia , Animais , Anti-Inflamatórios/química , Anti-Inflamatórios/farmacologia , Curcumina/química , Humanos , Sistema Imunitário/efeitos dos fármacos , Sistema Imunitário/imunologia , Sistema Imunitário/metabolismo , Fatores Imunológicos/química , Compostos Fitoquímicos/química , Compostos Fitoquímicos/farmacologia , Extratos Vegetais/química , Transdução de Sinais/efeitos dos fármacos
17.
Pharmacol Res ; 124: 146-155, 2017 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-28811228

RESUMO

Population aging is an irreversible global trend with economic and socio-political consequences. One of the most invalidating outcomes of aging in the elderly is cognitive decline, leading to dementia and often related to neurodegenerative disorders. Among these latter, Alzheimer's disease (AD) is the major cause of dementia, affecting more than 30 million of individuals worldwide. To date, the treatment of AD remains a challenge because of an incomplete understanding of the events that lead to the selective neurodegeneration typical of Alzheimer's brains. There is an enormous global demand for new effective therapies and researchers are investigating new fields. One promising strategy is the use of nutraceuticals as integrative, complementary and preventive therapy. Curcumin is one example of natural product with anti-AD properties, with promising potential for prevention, treatment and diagnostic. The limitations in the use of curcumin as therapeutic are represented by its pharmacokinetics profile and the low bioavailability after oral administration. However, curcumin has been the focus of intense research for new drug development. Here we analyzed some new approaches that have been applied in the attempt to improve its use, particularly new formulations, changes in the way of administration, nanotechnology-based delivery systems and the hybridization strategy.


Assuntos
Doença de Alzheimer/tratamento farmacológico , Anti-Inflamatórios não Esteroides , Curcumina , Fármacos Neuroprotetores , Doença de Alzheimer/metabolismo , Animais , Anti-Inflamatórios não Esteroides/administração & dosagem , Anti-Inflamatórios não Esteroides/química , Anti-Inflamatórios não Esteroides/farmacologia , Anti-Inflamatórios não Esteroides/uso terapêutico , Curcumina/administração & dosagem , Curcumina/química , Curcumina/farmacologia , Curcumina/uso terapêutico , Composição de Medicamentos , Sistemas de Liberação de Medicamentos , Humanos , Fármacos Neuroprotetores/administração & dosagem , Fármacos Neuroprotetores/química , Fármacos Neuroprotetores/farmacologia , Fármacos Neuroprotetores/uso terapêutico
20.
Science ; 383(6682): 470, 2024 Feb 02.
Artigo em Inglês | MEDLINE | ID: mdl-38301013

RESUMO

Problem is so severe that an influential top-researchers list has excluded the entire field.

SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA